Experienced investors have a vital role to play in sprinkling some magic dust on emerging enterprises
HBAN (Halo Business Angel Network), the all-island organisation responsible for the promotion of business angel investment, and a joint initiative of Enterprise Ireland and InterTradeIreland, today announces that a number of the original HBAN investors in software developer Phorest have been bought out for a sum averaging 10 times their initial investment.
Angels talk a lot about mentoring, but how many know what it really means? If you can’t describe what a great mentor does, you’ve probably never been one. A great mentor relationship is actually a pretty rare and special thing. It doesn’t come about all that often, and it’s not something that can be forced.
HBAN (Halo Business Angel Network), the all-island organisation responsible for the promotion of business angel investment, and a joint initiative of Enterprise Ireland and InterTradeIreland, today announces that it was crowned Globally Networked Organisation 2018 at the EBAN (European Business Angel Network) Awards Ceremony held in Sofia, Bulgaria, on Monday 25th June.
CB Insights recently published a study on the most common reasons startups fail. They looked at the cause of death on 101 start-ups and, not surprisingly, "Market," "Cash" and "Team" were major factors. But what might surprise many is that all three of those factors out-ranked "competition" as a source of death. There is an adage that start-ups don’t get killed, they commit suicide. CB Insights' study lends some credence to that idea.
The European Business Angel Network (EBAN), which is the pan-European community for the early stage investors covering over 150 member organizations in more than 50 countries announced its new President today. Peter Cowley, serial entrepreneur, invested investor and UK Angel of the Year 2014-15, has been appointed by the association to take the lead of the organisation for the next two years.
One of the most controversial topics in the startup community relates to the issue of investing through convertible notes vs. investing through preferred stock. Much has been written about this topic for the past decade, and the debate continues to rage in the blogosphere even today.
Enterprise Ireland today launches its 2017 Seed and Venture Capital Report which details the four venture capital initiatives undertaken by Enterprise Ireland in partnership with the private sector. In 2017, the Enterprise Ireland Seed and Venture Capital Scheme supported 87 Irish based companies, with a total investment of €72 million.
There can be tremendous advantages to working with angels in groups. The key is the speed with which an entrepreneur can find her champions. There is more process, but the results justify the effort.
HBAN (Halo Business Angel Network), the all-island organisation responsible for the promotion of business angel investment, and a joint initiative of Enterprise Ireland and InterTradeIreland, today announces that its new London Syndicate plans to invest €3 million in Irish start-ups over the next three years.
First 50 HBAN members to get discount ticket!
The next Halo Business Angel Network’s (HBAN) London Syndicate event on June 13th at 17.30 in Rocketspace, 40 Islington High St, Angel, London. Annually HBAN presents 100 plus qualified deals to the Network and close out between 40 and 50 in any one year. The average angel investment in a deal a €285k, however, due to the syndicated nature of the deals 60% of individuals invest less than €50k per deal, with 30% less than €25k.In our first year with New York and Singapore we closed out 4 and 2 deals respectively and we are aiming to close out 3 to 5 deals with each annually.
ProVerum Medical, a spin-off from Trinity College Dublin with a mission to improve the lives of millions of men, has closed a $4.2 million seed investment. Atlantic Bridge University Fund led the investment round with participation from Enterprise Ireland along with several Irish and American angel investors including HBAN Medtech Syndicate, Irrus Investments, Boole and Xenium Capital. The investment will allow ProVerum to commence its first human trials in 2018 and brings the company’s total funding since it was established in 2015 to €4.6 million.
This blog post was originally published on Tech Ireland and has this excerpt has been reprinted with permission by the author. To read the rest of the post please click on the image below.